U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 1058

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr20:10624478
GRCh38:
Chr20:10643830
JAG1W803fsAlagille syndrome due to a JAG1 point mutationPathogenic
(Jul 1, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr20:10622488
GRCh38:
Chr20:10641840
JAG1K875fsAlagille syndrome due to a JAG1 point mutationLikely pathogenicno assertion criteria provided
3.
GRCh37:
Chr20:10623251
GRCh38:
Chr20:10642603
JAG1Alagille syndrome due to a JAG1 point mutationLikely pathogenic
(May 25, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr20:10637107
GRCh38:
Chr20:10656459
JAG1Alagille syndrome due to a JAG1 point mutationLikely pathogenic
(Jan 24, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr20:10653546
GRCh38:
Chr20:10672898
JAG1R64fsAlagille syndrome due to a JAG1 point mutationLikely pathogeniccriteria provided, single submitter
6.
GRCh37:
Chr20:10654126
GRCh38:
Chr20:10673478
JAG1L18RAlagille syndrome due to a JAG1 point mutationLikely pathogenic
(Oct 25, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr20:10620351
GRCh38:
Chr20:10639703
JAG1T1151fsAlagille syndrome due to a JAG1 point mutationPathogenic
(Jun 22, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr20:10628615
GRCh38:
Chr20:10647967
JAG1C572fsAlagille syndrome due to a JAG1 point mutationPathogenic
(Feb 23, 2023)
criteria provided, single submitter
9.
GRCh37:
Chr20:10632860
GRCh38:
Chr20:10652212
JAG1G309WAlagille syndrome due to a JAG1 point mutationUncertain significance
(Jun 23, 2021)
criteria provided, single submitter
10.
GRCh37:
Chr20:10639347
GRCh38:
Chr20:10658699
JAG1A155PAlagille syndrome due to a JAG1 point mutationLikely pathogenic
(Sep 16, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr20:10653329-10654278
JAG1Alagille syndrome due to a JAG1 point mutationPathogenic
(Mar 14, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr20:10625639
GRCh38:
Chr20:10644991
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jun 8, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr20:10628674
GRCh38:
Chr20:10648026
JAG1P552SAlagille syndrome due to a JAG1 point mutationUncertain significance
(Apr 10, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr20:10639096
GRCh38:
Chr20:10658448
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Apr 1, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr20:10620413
GRCh38:
Chr20:10639765
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jul 17, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr20:10621805-10621811
GRCh38:
Chr20:10641157-10641163
JAG1I1000fsAlagille syndrome due to a JAG1 point mutationLikely pathogenic
(Nov 21, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr20:10624490
GRCh38:
Chr20:10643842
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jul 15, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr20:10622532
GRCh38:
Chr20:10641884
JAG1R861GAlagille syndrome due to a JAG1 point mutationBenign
(Jun 22, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr20:10620393
GRCh38:
Chr20:10639745
JAG1K1137RAlagille syndrome due to a JAG1 point mutationLikely benign
(Jul 29, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr20:10653585
GRCh38:
Chr20:10672937
JAG1N51DAlagille syndrome due to a JAG1 point mutationUncertain significance
(May 12, 2022)
criteria provided, single submitter
21.
GRCh37:
Chr20:10630924
GRCh38:
Chr20:10650276
JAG1P402QAlagille syndrome due to a JAG1 point mutationUncertain significance
(Nov 28, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr20:10632354
GRCh38:
Chr20:10651706
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Mar 21, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr20:10620298
GRCh38:
Chr20:10639650
JAG1R1169WAlagille syndrome due to a JAG1 point mutationLikely benign
(Aug 9, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr20:10630198
GRCh38:
Chr20:10649550
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Mar 18, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr20:10653363
GRCh38:
Chr20:10672715
JAG1S125GAlagille syndrome due to a JAG1 point mutationLikely benign
(Sep 27, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr20:10653565
GRCh38:
Chr20:10672917
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Mar 4, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr20:10633187
GRCh38:
Chr20:10652539
JAG1V272DAlagille syndrome due to a JAG1 point mutationUncertain significance
(Sep 21, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr20:10620272
GRCh38:
Chr20:10639624
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Sep 6, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr20:10622090
GRCh38:
Chr20:10641442
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jun 14, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr20:10632858
GRCh38:
Chr20:10652210
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Apr 7, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr20:10625857
GRCh38:
Chr20:10645209
JAG1Y721NAlagille syndrome due to a JAG1 point mutationUncertain significance
(Dec 15, 2021)
criteria provided, single submitter
32.
GRCh37:
Chr20:10621800
GRCh38:
Chr20:10641152
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Nov 1, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr20:10653517
GRCh38:
Chr20:10672869
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Feb 22, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr20:10624998
GRCh38:
Chr20:10644350
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Aug 10, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr20:10621490
GRCh38:
Chr20:10640842
JAG1S1047LAlagille syndrome due to a JAG1 point mutationLikely benign
(May 11, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr20:10620501
GRCh38:
Chr20:10639853
JAG1S1101NCardiovascular phenotype, Alagille syndrome due to a JAG1 point mutationConflicting interpretations of pathogenicity
(Jan 22, 2023)
criteria provided, conflicting interpretations
37.
GRCh37:
Chr20:10623261
GRCh38:
Chr20:10642613
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jun 10, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr20:10621883
GRCh38:
Chr20:10641235
JAG1T976ACardiovascular phenotype, Alagille syndrome due to a JAG1 point mutationUncertain significance
(Jan 25, 2023)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr20:10625045
GRCh38:
Chr20:10644397
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Aug 16, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr20:10632257
GRCh38:
Chr20:10651609
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Aug 1, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr20:10620347
GRCh38:
Chr20:10639699
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Dec 24, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr20:10632852
GRCh38:
Chr20:10652204
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(May 16, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr20:10628761
GRCh38:
Chr20:10648113
JAG1Alagille syndrome due to a JAG1 point mutationUncertain significance
(Jul 7, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr20:10630241
GRCh38:
Chr20:10649593
JAG1S426FAlagille syndrome due to a JAG1 point mutationUncertain significance
(Oct 9, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr20:10620327
GRCh38:
Chr20:10639679
JAG1D1159VAlagille syndrome due to a JAG1 point mutationUncertain significance
(Jul 18, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr20:10654127
GRCh38:
Chr20:10673479
JAG1L18FAlagille syndrome due to a JAG1 point mutationUncertain significance
(Oct 8, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr20:10628749
GRCh38:
Chr20:10648101
JAG1D527NAlagille syndrome due to a JAG1 point mutationUncertain significance
(Mar 26, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr20:10644600
GRCh38:
Chr20:10663952
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Sep 6, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr20:10625046
GRCh38:
Chr20:10644398
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Sep 27, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr20:10625801
GRCh38:
Chr20:10645153
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Apr 23, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr20:10620404
GRCh38:
Chr20:10639756
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Aug 16, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr20:10653404
GRCh38:
Chr20:10672756
JAG1A111VAlagille syndrome due to a JAG1 point mutationLikely benign
(Mar 26, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr20:10654153
GRCh38:
Chr20:10673505
JAG1R9PAlagille syndrome due to a JAG1 point mutationUncertain significance
(Mar 9, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr20:10639133
GRCh38:
Chr20:10658485
JAG1G226DAlagille syndrome due to a JAG1 point mutationUncertain significance
(Jul 30, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr20:10621498
GRCh38:
Chr20:10640850
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Apr 7, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr20:10629352
GRCh38:
Chr20:10648704
JAG1R472CInborn genetic diseases, Alagille syndrome due to a JAG1 point mutationConflicting interpretations of pathogenicity
(Jun 9, 2022)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr20:10629305
GRCh38:
Chr20:10648657
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(May 30, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr20:10653663
GRCh38:
Chr20:10673015
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Mar 20, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr20:10632230
GRCh38:
Chr20:10651582
JAG1Alagille syndrome due to a JAG1 point mutationUncertain significance
(Jul 30, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr20:10639244
GRCh38:
Chr20:10658596
JAG1D189GCardiovascular phenotype, Alagille syndrome due to a JAG1 point mutationConflicting interpretations of pathogenicity
(Dec 16, 2022)
criteria provided, conflicting interpretations
61.
GRCh37:
Chr20:10631028
GRCh38:
Chr20:10650380
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Apr 28, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr20:10626601-10626602
GRCh38:
Chr20:10645953-10645954
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Oct 7, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr20:10639151
GRCh38:
Chr20:10658503
JAG1C220FAlagille syndrome due to a JAG1 point mutationPathogenic
(Aug 19, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr20:10637085-10637086
GRCh38:
Chr20:10656437-10656438
JAG1S239fsAlagille syndrome due to a JAG1 point mutationPathogenic
(Feb 11, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr20:10630940
GRCh38:
Chr20:10650292
JAG1K397*Alagille syndrome due to a JAG1 point mutationPathogenic
(Jan 21, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr20:10623135
GRCh38:
Chr20:10642487
JAG1Alagille syndrome due to a JAG1 point mutationPathogenic
(Jan 1, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr20:10621432-10621433
GRCh38:
Chr20:10640784-10640785
JAG1D1067fsAlagille syndrome due to a JAG1 point mutationPathogenic
(Dec 11, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr20:10628775
GRCh38:
Chr20:10648127
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jul 6, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr20:10622234
GRCh38:
Chr20:10641586
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jul 12, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr20:10627627
GRCh38:
Chr20:10646979
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jul 1, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr20:10639149
GRCh38:
Chr20:10658501
JAG1M221VAlagille syndrome due to a JAG1 point mutationLikely benign
(May 7, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr20:10620472
GRCh38:
Chr20:10639824
JAG1T1111AAlagille syndrome due to a JAG1 point mutationUncertain significance
(May 4, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr20:10629374-10629375
GRCh38:
Chr20:10648726-10648727
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(May 3, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr20:10632858
GRCh38:
Chr20:10652210
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(May 12, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr20:10620268
GRCh38:
Chr20:10639620
JAG1V1179IAlagille syndrome due to a JAG1 point mutationUncertain significance
(Apr 24, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr20:10633136
GRCh38:
Chr20:10652488
JAG1G289DAlagille syndrome due to a JAG1 point mutationUncertain significance
(Apr 24, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr20:10653426
GRCh38:
Chr20:10672778
JAG1G104SAlagille syndrome due to a JAG1 point mutationUncertain significance
(Apr 24, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr20:10627666
GRCh38:
Chr20:10647018
JAG1H602QAlagille syndrome due to a JAG1 point mutationUncertain significance
(Apr 13, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr20:10630998
GRCh38:
Chr20:10650350
JAG1D377EAlagille syndrome due to a JAG1 point mutationUncertain significance
(Aug 16, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr20:10620548
GRCh38:
Chr20:10639900
JAG1L1085FAlagille syndrome due to a JAG1 point mutationUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr20:10621837
GRCh38:
Chr20:10641189
JAG1N991TAlagille syndrome due to a JAG1 point mutationUncertain significance
(Mar 28, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr20:10639367
GRCh38:
Chr20:10658719
JAG1P148fsAlagille syndrome due to a JAG1 point mutationPathogenic
(Mar 27, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr20:10621778
GRCh38:
Chr20:10641130
JAG1E1011QAlagille syndrome due to a JAG1 point mutationUncertain significance
(Mar 26, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr20:10632914
GRCh38:
Chr20:10652266
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Mar 17, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr20:10621792
GRCh38:
Chr20:10641144
JAG1P1006RAlagille syndrome due to a JAG1 point mutationUncertain significance
(Mar 15, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr20:10626039
GRCh38:
Chr20:10645391
JAG1C693SAlagille syndrome due to a JAG1 point mutationUncertain significance
(Mar 12, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr20:10633164
GRCh38:
Chr20:10652516
JAG1W280GAlagille syndrome due to a JAG1 point mutationUncertain significance
(Oct 5, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr20:10622088-10622091
GRCh38:
Chr20:10641440-10641443
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Oct 24, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr20:10630301
GRCh38:
Chr20:10649653
JAG1, MIR6870Alagille syndrome due to a JAG1 point mutationLikely benign
(Mar 9, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr20:10621414
GRCh38:
Chr20:10640766
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jul 27, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr20:10623135
GRCh38:
Chr20:10642487
JAG1Alagille syndrome due to a JAG1 point mutationPathogenic
(Feb 12, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr20:10653561
GRCh38:
Chr20:10672913
JAG1R59WAlagille syndrome due to a JAG1 point mutationUncertain significance
(Feb 6, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr20:10625526
GRCh38:
Chr20:10644878
JAG1P777TAlagille syndrome due to a JAG1 point mutationUncertain significance
(May 26, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr20:10629373
GRCh38:
Chr20:10648725
JAG1Alagille syndrome due to a JAG1 point mutationUncertain significance
(Oct 18, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr20:10632791
GRCh38:
Chr20:10652143
JAG1N332YAlagille syndrome due to a JAG1 point mutationUncertain significance
(Feb 2, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr20:10653536
GRCh38:
Chr20:10672888
JAG1T67SAlagille syndrome due to a JAG1 point mutationUncertain significance
(Jan 31, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr20:10623127
GRCh38:
Chr20:10642479
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Jan 31, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr20:10623203
GRCh38:
Chr20:10642555
JAG1C835*Alagille syndrome due to a JAG1 point mutationPathogenic
(Jan 21, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr20:10625988
GRCh38:
Chr20:10645340
JAG1Alagille syndrome due to a JAG1 point mutationLikely benign
(Oct 13, 2022)
criteria provided, single submitter
100.
GRCh37:
Chr20:10623132
GRCh38:
Chr20:10642484
JAG1Alagille syndrome due to a JAG1 point mutationUncertain significance
(Jun 22, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination